ADARx Pharmaceuticals, Inc. (ADRX) vs Neutron Holdings, Inc. (LIME)

A side-by-side comparison of ADARx Pharmaceuticals, Inc. and Neutron Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADRX

ADARx Pharmaceuticals, Inc.

$1.91B

$18.66IndustrialsDelayed quote: Oct 6, 2026, 10:44 AM EDT

LIME

Neutron Holdings, Inc.

$1.79B

$27.91IndustrialsDelayed quote: Oct 6, 2026, 10:40 AM EDT

Total return — ADRX vs LIME

growth of $100 · dividends reinvested · last 1y

ADRX -1.6% (-1.6%/yr)LIME -7.0% (-7.0%/yr)ADRX compounded faster over this window

ADRX LIME

Metrics side by side

ADRX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ADRX analysis Full LIME analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.